Results 21 to 30 of about 38,650 (259)

Immunophenotyping of Tumours [PDF]

open access: yesMedical Journal Armed Forces India, 2008
Immunophenotyping has added a new dimension to improve the diagnostic accuracy of malignant diseases. The emphasis is on its usefulness in planning and institution of specific therapy besides helping in prognostication.The study included 83/1385 biopsies of cancer patients over an 18 month period on which immunohistochemical staining (IHC) with ...
R, Lakhtakia, S K, Nema
openaire   +2 more sources

Immunophenotyping of Childhood Acute Lymphoblastic Leukemia in Qazvin City, Iran: A Cross-Sectional Study

open access: yesThe Journal of Qazvin University of Medical Sciences, 2023
Background:Acute lymphoblastic leukemia (ALL) is the most prevalent childhood cancer. ALL is a heterogeneous type of malignancy and treatment protocols vary based on the immunological classification of ALL.
Majid Vafaie   +3 more
doaj   +1 more source

Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis Through Immunophenotyping

open access: yesFrontiers in Neurology, 2020
Quantifying cell subpopulations in biological fluids aids in diagnosis and understanding of the mechanisms of injury. Although much has been learned from cerebrospinal fluid (CSF) flow cytometry in neuroimmunological disorders, such as multiple sclerosis
Paavali A. Hannikainen   +3 more
doaj   +1 more source

Interpreting flow cytometry with caution: A case report of follicular lymphoma in leukemic phase misdiagnosed as chronic lymphocytic leukemia

open access: yesFrontiers in Oncology, 2023
Chronic lymphocytic leukemia (CLL) is a subtype of mature B-cell proliferative neoplasms characterized by abnormally increasing lymphocytes in circulation.
Yuan Ren   +5 more
doaj   +1 more source

Transformation of acute lymphoblastic leukemia with a precursor B-cell immunophenotype to burkitt’s lymphoma: A case report [PDF]

open access: yesCaspian Journal of Internal Medicine, 2023
Background: As a new point, some very rare features can be revealed as initial diagnosis of acute lymphoblastic leukemia (ALL) without any evidence of lymphoma-like behavior which after initial recovery, presents with new evidence of lymphoma.
Masoumeh Jafari   +2 more
doaj  

Study of immunophenotypic markers and clinico-hematological findings in chronic lymphocytic leukemia

open access: yesZanco Journal of Medical Sciences, 2023
Background and objective: Chronic lymphocytic leukemia (CLL) is a clonal, mature B-cell neoplasm, its clinical features, cell morphology, and immunophenotyping are used to establish the diagnosis.
Ansam Mazin Butrous   +1 more
doaj   +1 more source

A single centre phase II trial to assess the immunological activity of TroVax® plus pemetrexed/cisplatin in patients with malignant pleural mesothelioma – the SKOPOS trial

open access: yesOncoImmunology, 2018
Vaccines in combination with chemotherapy have been shown to be safe in different tumor types. We investigated the immunological activity of the TroVax® vaccine in combination with pemetrexed-cisplatin chemotherapy in malignant pleural mesothelioma (MPM).
Jason F Lester   +7 more
doaj   +1 more source

Células dendríticas foliculares: imunofenotipagem no linfoma de Hodgkin clássico esclerose nodular Dendritic follicular cells: immunophenotyping in classic Hodgkin’s lymphoma nodular sclerosis

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2006
O linfoma de Hodgkin clássico esclerose nodular (LHCEN), de origem linfóide da célula B do centro germinativo (CG), apresenta agregados de células dendríticas foliculares (CDF), célula Hodgkin/Reed Sternberg e variantes, células B formando complexos ...
Julieta M. M. F. Almeida   +5 more
doaj   +1 more source

Highly Multiplexed Phenotyping of Immunoregulatory Proteins in the Tumor Microenvironment by CODEX Tissue Imaging

open access: yesFrontiers in Immunology, 2021
Immunotherapies are revolutionizing cancer treatment by boosting the natural ability of the immune system. In addition to antibodies against traditional checkpoint molecules or their ligands (i.e., CTLA-4, PD-1, and PD-L1), therapies targeting molecules ...
Darci Phillips   +8 more
doaj   +1 more source

Application and interpretation of immunophenotyping data in safety and risk assessment

open access: yesFrontiers in Toxicology
The use of immunophenotyping during immunotoxicity investigations was first popularized in the 1980 s and has since become more integrated into diagnostic and non-clinical assessments.
Victor J. Johnson   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy